Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer Bulks Up Its Generics Business

This article was originally published in The Pink Sheet Daily

Executive Summary

Deal with the Indian pharma company Aurobindo highlights the giant’s interest in expanding its product mix.

You may also be interested in...



Pfizer Ramps Up Its Biosimilars Business

Strategy includes launching 10 monoclonal antibodies by 2016 at the earliest

Pfizer Ramps Up Its Biosimilars Business

Strategy includes launching 10 monoclonal antibodies by 2016 at the earliest

Pfizer Leaps Into Japanese Generics Foray; Aims For 100 Generic Products By 2011

Pfizer's Established Products Business Unit, a branch in charge of invigorating off-patent drugs and leading generic drug activities, will establish commercial operations in Japan starting Dec. 1

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS069199

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel